|
Match
|
Document |
Document Title |
|
|
5202126 |
Composition containing pregnenolone or a pregnenolone ester incorporated in liposomes, and a method for regenerating, or revitalizing the skin therewith
The present invention relates to a composition based on hydrated lipidic lamellar phases or on liposomes. In this composition, pregnenolone or a pregnenolone ester, such as, in particular,...
|
|
|
5194248 |
Compositions comprising vitamin D analog precursors and the use thereof
Methods for providing vitamin D analogs to an individual with topical compositions comprising tachysterol and luministerol analogs are disclosed. Optionally, the compositions may comprise one or...
|
|
|
5192754 |
Fish stress resistance method
A method of relieving stress in fish and increasing resistance to pathogenic agents comprising orally administering to the fish an amount of a compound of the formula ##STR1## wherein R is alkyl of...
|
|
|
5183814 |
Selective oestrogen therapy for perimenopausal or postmenopausal conditions
The invention relates to a therapeutic product comprising an oestrogen and a pure antioestrogen for simultaneous, sequential or separate use in selective oestrogen therapy of perimenopausal or...
|
|
|
5149526 |
Use of cholesteryl esters as mounting sex pheromones in combination with 2,6-dichlorophenol and pesticides to control populations of hard ticks
Compositions, methods and apparatus provide for the control of Ixodid hard tick populations. The compositions comprise a cholesteryl ester and 2,6-dichlorophenol. In combination, these compounds...
|
|
|
5147869 |
Zootechnical compositions
A zootechnical association comprising a) a zootechnical composition containing 10 to 1,000 mg of salbutamol and 5 to 50 mg of trenbolone acetate and a method increasing the weight and quality of...
|
|
|
5140012 |
Method for preventing onset of restenosis after angioplasty employing pravastatin
A method is provided for preventing or reducing the risk of restenosis following angioplasty by administering pravastatin alone or in combination with an ACE inhibitor such as captopril or...
|
|
|
5122520 |
Acid addition salts of amidated taurine or glycine, their preparation and use
Acid addition salt of taurine or glycine, their amino group being amidated with a carboxylic acid residue which contains the structure of a 3α, 7α, 12α-trihydroxysteroid, their acid group being...
|
|
|
5116828 |
Pharmaceutical composition for treatment of osteoporosis
A pharmaceutical composition for the treatment of osteoporosis comprises an estrogen and a thyroid hormone as effective ingredients. By using the estrogen in combination with the thyroid hormone, a...
|
|
|
5110809 |
Antifungal gel formulations
Stable anhydrous gel formulations for topical antifungal use contain an imidazole, a steroid, a co-solvent system comprising monohydric and dihydric alcohols, and a hydroxyalkylcellulose gellant.
|
|
|
5098889 |
Method for preventing or inhibiting loss of cognitive function employing a combination of an ace inhibitor and a drug that acts at serotonin receptors
A method is provided for imhibiting loss of cognitive functon, including memory, which may or may not be associated with Alzheimer's disease, by administering an ACE inhibitor, such as captopril,...
|
|
|
5096892 |
Arylsulfatase inhibition and potentiation of angiostatic steroids and heparin
Anigiogenesis is controlled by administering to a mammal an effective amount of an inhibitor of arylsulfatase. Preferably, the arylsulfatase inhibitor is administered in a pharmaceutically...
|
|
|
5095010 |
Antigestagens, glucocorticoids and prostaglandins for induction of labor or for termination of pregnancy
Combination products containing an antigestagen, a glucocorticoid and a prostaglandin are suitable for combined use in inducing labor or terminating pregnancy.
|
|
|
5087620 |
Controlled dermal penetration enhancement using imidazoles
Topical compositions are described which contain a vehicle which is free of lower alkanols, a pharmacologically active agent whose dermal penetration can be enhanced and a unique penetration...
|
|
|
5080885 |
Brominated perfluorocarbon emulsions for internal animal use for contrast enhancement and oxygen transport
A non-toxic, brominated perfluorocarbon emulsion for internal and intravenous use in animals (including humans) is disclosed, for use as an oxygen transport medium and as a contrast enhancement...
|
|
|
5077284 |
Use of dehydroepiandrosterone to improve immune response
The steroid hormone dehydroepiandrosterone (DHEA), when administered by feeding or by subcutaneous injection, significantly improves the host response to viral infection. Experimental animal data...
|
|
|
5069905 |
Method and compositions comprising a vitamin D derivatives for the local treatment of bone fractures
A method for the treatment and promotion of healing of bone fractures and osteotomies in warm-blooded animals including humans, which comprises local application to the site of the fracture or...
|
|
|
5061700 |
Glyceryl acetate ointment vehicles
Compositions of matter serving as topical ointment vehicles and comprising a glyceryl acetate, preferably triacetin, and an oleaginous material that can be combined with a medicament, preferably a...
|
|
|
5053403 |
Methods for treatment of male-pattern baldness
Synergistic compositions for inhibiting the action of androgens comprise the combination in a single topical preparation of a 5α-reductase enzyme inhibitor and an androgen receptor blocking agent...
|
|
|
5043329 |
Methods and compositions employing unique mixtures of polar and neutral lipids for protecting the gastrointestinal tract
Disclosed are compositions composed of unique mixtures of phospholipids and neutral lipids and methods of employing such compositions to treat the luminal lining of the gastrointestinal tract in...
|
|
|
5036087 |
Clathrate compound
A clathrate compound comprising a water-soluble microbicide and at least one of (a) a bisphenol compound represented by formula (I) and (b) deoxycholic acid represented by formula (II): (a)...
|
|
|
5034221 |
Topical agent and method for the treatment of Pseudofolliculitis barbae
A topical agent and method for the treatment and prevention of pseudofolliculitis barbae, commonly known as "razor bumps", is effected by the topical application to beard areas of the face of a...
|
|
|
5032578 |
Method for preventing or treating depression employing a combination of an ace inhibitor and a drug that acts at serotonin receptors
A method is provided for inhibiting onset of or treating depression by administering an ACE inhibitor, such as captopril, fosinopril, zofenopril or ceranapril in combination with a drug that acts...
|
|
|
5026691 |
Combination of minoxidil and an antiinflammatory agent for treating patterned alopecia
This invention relates to the method for treating human baldness, including the form of alopecia commonly known as "male pattern baldness", which comprises regular topical application to the...
|
|
|
5021404 |
Angiostatic collagen modulators
Angiostatic compounds are potentiated by collagen matrix metabolism modulators including: a) proline analogs which inhibit proline hydroxylation when substituted for proline in collagen; b)...
|
|
|
5019568 |
Steroidal glycolipids as host resistance stimulators against viral infection
Disclosed are pharmaceutical compositions for enhancing human host resistance against opportunistic infection in an individual immunocompromised by an AIDS-related virus, consisting essentially of...
|
|
|
5019569 |
Reversal of glucocorticoid-induced skin atrophy
The present invention is directed to the topical administration of a retinoid-containing pharmaceutical composition for reversing the effects of glucocorticoid-induced skin atrophy.
|
|
|
5019395 |
Compositions with enhanced penetration
Penetration of various drugs through living membranes is improved by their use in transdermal compositions containing certain penetration-enhancing systems. A new delivery device is also described.
|
|
|
5017567 |
Carboxyalkyl dipeptides as antiglaucoma agents
Methods and pharmaceutical compositions are disclosed for reducing intraocular pressure. The methods and compositions employ an active ingredient which comprises certain benzothiadiazinyl and...
|
|
|
5015633 |
Method for inhibiting loss of cognitive functions employing an ace inhibitor
A method is provided for inhibiting loss of cognitive function, including memory, which may or may not be associated with Alzhemier's disease, in a mammalian species by administering an ACE...
|
|
|
5013728 |
Composition for treating osteoporosis and hormonal imbalance
A medication for providing fluoride ion for the prevention and treatment of bone loss disease, together with an estrogen-containing substance for not only treating hormonal imbalance but to obtain...
|
|
|
5011678 |
Composition and method for administration of pharmaceutically active substances
Pharmaceutically active substances are administered in aerosol form by applying to a mucosal surface of the body a composition comprising a medically effective amount of a pharmaceutically active...
|
|
|
5010070 |
Graduated estrogen contraceptive
Contraceptive methods and delivery systems involving few undesirable side effects during administration are based on novel triphasic estrogen/progestogen combinations, wherein the amount of...
|
|
|
5001116 |
Inhibition of angiogenesis
Angiogenesis in mammals is inhibited by administration of the active agents (1) heparin or a heparin fragment which is a hexasaccharide or larger or analogous compounds and (2) a steroid having...
|
|
|
4999348 |
Liquid crystal containing cosmetic and pharmaceutical compositions and methods for utilizing such compositions
Cosmetic and pharmaceutical compositions and methods comprising delivery systems for the controlled release and enhanced penetration of biologically active materials (e.g., Vitamin A) to the skin....
|
|
|
4997823 |
Anti-infective injectable formulations
Infection associated with parenteral injections of parenterally suitable compounds, especially of F 2 α prostaglandins, is prevented by novel compositions comprising such compounds, a locally...
|
|
|
4997825 |
Synergistic treatment method
The concentration of endogenous growth hormone in the bloodstream of an economic mammal is increased by the simultaneous administration of an estrogen and a growth hormone releasing factor.
|
|
|
4994449 |
Method for increasing bone density in humans
A method of increasing the bone density of post-menopausal women employs a calendar-oriented regimen of estrogen, progesterone and calcium. Such a regimen may be dispensed from a calendar-oriented...
|
|
|
4994439 |
Transmembrane formulations for drug administration
Compositions for the administration of protein or peptide drugs across membranes show low toxicity and efficient permeation when the medium is a mixture of a bile salt or fusidate with a nonionic...
|
|
|
4977147 |
17-methylene- and 17-ethylidene-estratrienes
A pharmaceutical preparation for treating menopausal symptoms, estrogen deficiency and hormone-dependent tumors, and for use as a contraceptive, comprises a compound of formula I ##STR1## wherein R...
|
|
|
4963346 |
Method and composition for treatment or prevention of dental plaque calculus and gingivitis
A method and composition is presented for the treatment or prevention of dental plaque, calculus and gingivitis. The method comprises either systemically or topically treating the oral cavity for a...
|
|
|
4959358 |
Drug administration
Compositions and methods useful for the prevention or treatment of a human or animal disorder or for the regulation of the human or animal physiological condition are provided. The compositions...
|
|
|
4956355 |
Agents for the arrest and therapy of retroviral infections
Compounds of the general Formula (I) ##STR1## in which R is a hydrogen atom or a bromine atom, and R 1 is a hydrogen atom, an SO 2 OM group wherein M is a hydrogen or sodium atom, various...
|
|
|
4945103 |
Method of treating pre-menstrual syndrome
A method of treating human females who suffer from pre-menstrual syndrome (PMS) comprises administering melatonin in sufficient doses to relieve the symptoms of PMS.
|
|
|
4945089 |
Use of tetrahydrocortexolone to prevent elevations in intraocular pressure caused by corticosteroids
Pharmaceutical compositions useful in the treatment of ophthalmic inflammation and methods of treating ophthalmic inflammation with those compositions are disclosed. The compositions contain a...
|
|
|
4920109 |
Antifungal compositions and method of controlling mycotic infections
Method of potentiating antifungal agents with 25-azasterol compound to produce superior antifungal compositions and use of the compositions to control mycotic infections is disclosed.
|
|
|
4920113 |
Fungicidal compositions and methods utilizing 25-azasterol and HMG-CoA synthase inhibitors
Novel fungicidal compositions comprising a 25-azasterol compound and a HMG-CoA synthase inhibitor compound are disclosed.
|
|
|
4914090 |
Ophthalmic compositions
The use of an angiotensin converting enzyme inhibitor for reducing and controlling the elevation of intraocular pressure associated with the use of corticosteroids is disclosed. Also disclosed are...
|
|
|
4904648 |
Pharmaceutical preparations for induction of labor and for contraceptive use
The present invention relates to a pharmaceutical combination product for the induction of labor or for preventing the development of pregnancy, containing (A) one or more antigestagen(s) (B)...
|
|
|
4900734 |
Novel pharmaceutical composition containing estradiol and progesterone for oral administration
A pharmaceutical composition is provided for oral administration. The composition comprises estradiol dissolved in an oil vehicle containing a suspension of micronized progesterone. The oil vehicle...
|